Canada Generic Drugs Market 2018: Market Structure — Impacts Trends, Growth, Share, Opportunities And Forecast To 2023 - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Canada Generic Drugs Market 2018: Market Structure — Impacts Trends, Growth, Share, Opportunities And Forecast To 2023

Description:

Get more information about the market: The Canada generic drugs market reached a value of US$ 6.0 Billion in 2017. Generic drug refers to a medication that has the same active ingredients and therapeutic effect as that of a branded drug. These drugs can be oral, intravenous, intramuscular, topical or inhalant. Want more information about this market? Request a free report sample: Contact Us IMARC Group USA: +1-631-791-1145 Email: sales@imarcgroup.com Website: Follow us on twitter : @imarcglobal – PowerPoint PPT presentation

Number of Views:8

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Canada Generic Drugs Market 2018: Market Structure — Impacts Trends, Growth, Share, Opportunities And Forecast To 2023


1

Public Drug Programs Propelling Canada Generic
Drugs Market Growth
Copyright IMARC. All Rights Reserved
2
About IMARC Group
Report Description
IMARC is a leading advisor on management
strategy and market research worldwide. We
partner with clients in all sectors and regions
to identify their highest-value opportunities,
address their most critical challenges, and
transform their businesses. IMARCs information
products include major market, scientific,
economic and technological developments for
business leaders in pharmaceutical, industrial,
and high technology organizations. Market
forecasts and industry analysis for
biotechnology, advanced materials,
pharmaceuticals, food and beverage, travel and
tourism, nanotechnology and novel processing
methods are at the top of the companys
expertise. IMARCs tailored approach combines
unfathomable insight into the dynamics of
companies and markets with close cooperation at
all levels of the client organization. This
ensures that our clients achieve unmatchable
competitive advantage, build more proficient
organizations, and secure lasting results.
3
Report Description and Highlights
Report Description
Public Drug Programs Propelling Canada Generic
Drugs Market Growth The Canada generic drugs
market has witnessed a steady growth over the
past several years. This can be accredited to the
aging population coupled with increasing
government support for research and development
in the pharmaceutical industry. The latest
report by IMARC Group, titled Canada Generic
Drugs Market Industry Trends, Share, Size,
Growth, Opportunity and Forecast 2018-2023,
finds that the Canada generic drugs
market reached a value of US 6.0 Billion in
2017. Generic drug refers to a medication that
has the same active ingredients and therapeutic
effect as that of a branded drug. These drugs can
be oral, intravenous, intramuscular, topical or
inhalant. Generic drugs do not involve marketing
on a large-scale due to the established safety
and efficacy profile of their branded
counterparts. Moreover, they are almost 5 times
cheaper than branded drugs as they do not require
extensive research and clinical trials which save
both money and time for the manufacturers. At
present, Canada is the ninth-largest generic drug
market worldwide, accounting for nearly 3 of the
global share. Over the past several years, the
acceptance of generic drugs in Canada has
increased, and these drugs now account for around
70 of the total retail prescriptions in the
country.
4
Report Description and Highlights
Report Description
Canada Generic Drugs Market Trends Canada
continues to face substantial healthcare
challenges in terms of rising prevalence of
lifestyle and chronic diseases such as
depression, cardiovascular diseases (CVDs),
cancer, chronic respiratory diseases (CRDs),
diabetes and anxiety disorders. This, coupled
with the growing geriatric population, has
created a huge demand for cost-effective drugs in
the country. The government has introduced public
drug programs such as the Ontario Drug Benefit
(ODB) Program and Trillium Drug Program as an
initiative to provide universal healthcare in the
country. Although these programs utilize both
brand-name and generic drugs, they encourage the
physicians and patients to opt for generic
medicines wherever available so as to reduce the
overall drug expenditure. In addition, the
Canadian government is supporting RD activities
so as to strengthen the countrys expertise in
specialty areas and biotech products. The rising
number of patent expiries of branded drugs is
further expanding the growth prospects of the
generic drugs market in the region. However, the
higher price of generic drugs available in
Canada, as compared to the other industrialized
countries, have been responsible for hampering
the growth of the market. Looking forward, the
generic drugs market in Canada is projected to
reach a value of US 6.7 Billion by 2023, growing
at a CAGR of 1.9 during 2018-2023. Read more
here http//bit.ly/2Fpkujz
5
Report Description and Highlights
Report Description
  Want more information about
this market? Request a free report
sample https//www.imarcgroup.com/request?typere
portid700flagB
6
Report Description and Highlights
Canada Generic Drugs Market Competitive
Landscape The Canada generic market is
concentrated in nature with the top five players
dominating the total market share. Some of the
key players operative in the market include Teva
Pharmaceutical Industries Limited, Apotex Inc.,
Sandoz Inc., Sun Pharma Industries Ltd.,
Pharmascience Inc., and Mylan N.V. Browse More
Related Reports  Generic Oncology Drug Market
http//bit.ly/2Ef2mIE Brazil Generic Drug
Market http//bit.ly/2zbPQVz
7
Report Description and Highlights
Report Description

2017 IMARC All Rights Reserved This
Publication and all its contents unless
otherwise mentioned are copyrighted in the name
of International Market Analysis Research and
Consulting (IMARC). No part of this publication
may be reproduced, repackaged, redistributed or
resold in whole or in any part. The publication
may also not be used in any form or by and means
graphic electronic or mechanical, including
photocopying, recording, taping or by information
storage or retrieval, or by any other form,
without the express consent of International
Market Analysis Research and Consulting
(IMARC). Disclaimer All contents and data of
this publication, including forecasts, data
analysis and opinion have been based on
information and sources believed to be accurate
and reliable at the time of publishing.
International Market Analysis Research and
Consulting makes no representation of warranty of
any kind as to the accuracy or completeness of
any Information provided. IMARC accepts no
liability whatsoever for any loss or damage
resulting from opinion, errors or inaccuracies if
any found this publication. IMARC, IMARC Group
and Global Therapy Insight Series are registered
trademarks of International Market Analysis
Research and Consulting. All other trademarks
used in this publication are registered
trademarks of their respective companies.
8

Contact Us
About PowerShow.com